Pharma
RAREsummit25: CamRARE at 10 – Connecting Moments
2025 marks a special milestone — CamRARE’s 10th anniversary. A decade of progress. A future of possibilities. Over the past decade, we have championed collaboration, amplified patient voices, and driven progress in rare disease research, policy, and innovation. Through inspiring keynot...
Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development
Collaboration combines Nuclera’s eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva’s Biacore SPR system, which characterizes molecular interactionsCollaboration allows researchers to progress rapidly from DNA to purified and...
Cambridge AI Club for Biomedicine - June - New Methods in AI
The AI Club brings together the Biomedical AI and Machine Learning community in Cambridge, to discuss common themes and explore different topics and methodologies. Talks will be followed by pizza and networking. June Theme - New Methods in AISpeakers: ...
SIRS 2025: Insights on Schizophrenia Research, From Rights Based Care to Digital Biomarkers
This year’s Schizophrenia International Research Society (SIRS) 2025 Congress in Chicago brought together leading scientists and researchers, exploring the latest advancements and ongoing challenges in understanding and addressing schizophrenia. Michael Spilka, PhD. shares his key insig...
Cambridge Cognition selected for two Phase 3 Trials combining digital cognitive and voice solutions
Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, has been selected by a major pharmaceutical company to provide digital cognitive and voice assessments for two Phase 3 clinical trials in ...
Cambridge Cognition Secures £1million Contract for Phase 3 Autoimmune Disease Trial
Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, has been selected by a major pharmaceutical company to provide digital cognitive assessments for a large Phase 3 autoimmune disease clinic...
Navigating tax: Essential strategies for R&D
With HMRC increasing its focus on tax governance, tax and finance teams face an increasing compliance burden, balancing value with risk management.When it comes to R&D tax relief processes, knowing what actions you need to take and when is challenging, especially against a backdrop ...
Cleanroom Solutions embracing the future to elevate their large-scale facility construction provision
The Guardtech Group’s heritage turnkey brand are utilising state-of-the-art software to take their offering to another level ...
Innovating with AI: Regulatory Opportunities and Key Requirements in the UK and the EU
This webinar will introduce you to the United Kingdom's and the European Union's pro-innovation approaches to artificial intelligence (AI) development and use, including for research purposes and in clinical settings. ...
Innovating with Health Data: Regulatory opportunities and key requirements in the UK and the EU
This webinar will introduce you to policy and regulatory initiatives in the UK and the European Union to provide enhanced access to health data for biomedical research purposes. ...